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In the study, on the basis of statistical analysis of the complex 
of clinical-laboratory, anamnestic and immunological param-
eters of 495 patients, predictors of pneumonia were deter-
mined and a logistic model of the prediction of the occurrence 
of pneumonia in patients with immune disorders on the back-
ground of oncohematological pathology was developed, which 
included indicators that are characteristics of the course of 
oncological diseases of the blood, as well as indicators of im-
mune reactivity.
Key words: prognosis of pneumonia, oncohematological pathol-
ogy, immunity disorders.
Pneumonia, despite the implementation of modern interna-tional medical practice [1–3] and state standards of diagnosis 
and treatment [4], remains a significant clinical problem. Despite 
the decrease in the death rate from pneumonia in Ukraine in the 
last 12 years, the indicator of hospital mortality remains practi-
cally unchanged: 0,84 per 2010; 0,87 for 2011 [5].
One of the reasons for the high level of pneumonia is the 
increase in the number of patients with severe immune disor-
ders. These patients include patients with oncohematological 
pathology. According to statistical data in the United States 
about every 3 minutes a new case of oncohematological disease 
is registered, one in nine patients dying every 9 minutes [6]. In 
Ukraine, up to 8,000 new cases of hemoblastosis are diagnosed 
annually. Index of morbidity by 100 thousand the population 
is: at lymphogranulomatosis – 2,5; at multiple myeloma (MM) 
– 1,6; with leukemia – 8,1 [7]. The reduction of the immuno-
logical protective forces of the body of such patients is associ-
ated with both the specificity of the oncohematological process 
and the immunosuppressive effects of modern HT patterns. 
Immunological defects are observed at all levels of nonspecific 
reactivity. Violation of the immune response in patients is ac-
companied by changes in the processes of differentiation, pro-
liferation and adaptation of its cells, which lead to a decrease in 
the response of the cellular level of immunity [8]. 
Cytostatic therapy of oncohematological disease leads to a 
decrease in the concentration of immunoglobulins and causes dis-
orders of the humoral link. The presence of immunity disorders 
not only complicates the oncohematological disease but also be-
comes the cause of infectious complications, including pneumo-
nia, which, in turn, worsen both the prognosis of survival and the 
quality of life. The incidence of IC in patients with background 
oncohematological pathology is recorded in 30–80% of cases, in 
most cases it is pneumonia, which determine the greatest mor-
tality [9]. Pneumonia often occurs in patients with multiple my-
eloma, their proportion is 42%; in patients with non-Hodgkin’s 
lymphomas (NHL) – 79%. [10].
At the present stage, the development of medicine is based on 
the principles of evidence-based medicine, which requires the use 
of statistical methods and forecasting. If earlier the estimate of 
the onset of a disease or its consequences was based on the analy-
sis of only clinical data and the experience of a doctor, then the 
use of mathematical apparatus is currently possible. Quantitative 
analysis makes it possible to determine prognostic evaluation cri-
teria in numerical terms, which enriches and reinforces the con-
tent analysis, makes it more evidence, excluding contradictory 
methods [11]. 
Problematic questions regarding the evaluation of the factors 
influencing the occurrence of pneumonia and the prediction of 
its development on the background of programmed treatment of 
oncohematological diseases are important for clinicians working 
with this category of patients. In this regard, the practical impor-
tance of this problem determines the relevance of the study.
The objective: based on the statistical analysis of a complex 
of clinical and laboratory, anamnestic and immunological indi-
cators, to create a mathematical model for predicting the occur-
rence of pneumonia in patients with immune disorders on the 
background of oncohematological pathology.
MAteriAls And MetHods
The study group consisted of 495 patients who were hospital-
ized in the hematological center «City Multidisciplinary Clini-
cal Hospital № 4», Dnipro for examination and treatment (the 
retrospective stage included the analysis of data of 389 cases of 
hospitalization of patients, 2011–2014, prospective – 106 cases 
of hospitalizations, 2014–2016). The research was conducted in 
accordance with the ethical principles of the Helsinki Declara-
tion with the permission of the Bioethics Commission of the SE 
«Dnipropetrovsk Medical Academy of the Ministry of Health of 
Ukraine». 
Diagnosis of nosological form of oncological pathology was 
determined in accordance with generally accepted clinical and 
morphological criteria [12]; diagnosis of pneumonia – in accor-
dance with the criteria of the Order of the Ministry of Health of 
Ukraine No. 128 dated March 19, 2007 [4]. To solve this purpose, 
formalized histories of the illness of patients were created, where 
the results of clinical, instrumental and laboratory methods of 
investigation, including microbiological ones were presented. 
All indicators (132 quantitative and qualitative (nominal) indi-
cators), obtained in the study, were entered into the electronic 
database in the form of a table «object–sign», which was subse-
quently subjected to a phased, multidimensional mathematical 
and statistical processing. 
This allowed a fairly complete description of the various 
aspects of the state of the object of study and characterize: 
the course of pneumonia, the course of the main oncohema-
tological disease and the state of the immune system of pa-
tients. Peculiarities of the course of pneumonia were studied 
independently of the oncogematological disease course. The 
statistical processing of the research results was carried out 
using descriptive and analytical biostatistics methods imple-
mented in software packages STATISTICA 6.1 (StatSoftInc., 
Serial No. AGAR909E415822FA); Microsoft Excel (Office 
Home Business 2KB4Y-6H9DB-BM47K-749PV-PG3KT); 
MedCalc Statistical Software trial version 17.4 software pack-
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Table 1
Correlation between the presence of pneumonia and general clinical and laboratory indices of patients in study groups
indicators
ρ – the spirman rank correlation 
coefficients
р
Dyspnea -0,78 <0,001
RR, per min -0,62 <0,001
The degree of neutropenia, ×109/l -0,47 <0,001
Pleurisy -0,45 <0,001
Cough -0,44 <0,001
The presence of P. Aeroginosa -0,42 <0,001
Leucocytes, ×109/l -0,38 <0,001
FA, unit -0,38 <0,001
Number of courses of PCT -0,37 <0,001
Glycemia, mmol/l -0,34 <0,001
Pulse, per min -0,34 <0,001
T CD19,% -0,34 <0,001
B CD19,% -0,28 0,001
FF, unit. -0,26 0,002
Neutropenia 3 st. -0,26 <0,001
Stephen ABT -0,25 <0,001
Number of pathogens -0,21 <0,001
Urinary tract infection -0,17 <0,001
ESR, mm/h -0,17 <0,001
Defeat of the spleen -0,16 <0,001
CD8, % -0,15 0,041
Body temperature, oC -0,13 0,004
Stage for Anne – Arbor Classification -0,12 0,007
Defeat of lymph nodes -0,12 0,010
Lesion of the liver -0,11 0,011
Urea, mmol/l -0,11 0,016
Creatinine, μmol/l -0,09 0,041
Platelets, 109/l 0,1 0,03
AT systolic, mm rt.st. 0,13 0,004
Gr + flora 0,14 0,002
CD4, % 0,15 0,048
Hemoglobin, g/l 0,17 <0,001
Lymphocytes, % 0,19 0,006
DR +, % 0,19 0,032
СD4, g/l 0,27 0,001
Erythrocytes, 1012/l 0,27 <0,001
Weakened breath 0,30 <0,001
Reduced percussion sound 0,31 <0,001
CD4 / CD8 0,35 <0,001
Number of neutrophils, 109/l 0,41 <0,001
B CD19, G/L 0,61 <0,001
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Table 2
The ratio of chances of exposure to general clinical and laboratory parameters for the onset of pneumonia
indicators
(1 – yes, 0 – no)
rc 95% cІ
the proportion of patients,%
p*
subgroup A. subgroup b
Cough 8,42 5,29–13,42 88,76% 18,37% <0,001
Sputum 2,41 1,51–3,84 26,51% 0% <0,001
Reduced percussion sound 0,1 0,05–0,22 75,5% 6,75% <0,001
Weakened breath 0,15 0,08–0,28 72,69% 14,72% <0,001
Dyspnea 135,89 60,27–306,39 79,92% 2,85% <0,001
Pleurisy 251,71 15,51–4085,93 33,73% 0% <0,001
Defeat of lymph nodes 1,62 1,12–2,34 43,37% 32,11% <0,001
Defeat of the spleen 1,94 1,35–2,79 50,2% 34,15% 0,011
Defeat of the liver 1,61 1,11–2,33 69,48% 58,54% <0,001
Glycemia, mmol/l 5,46 3,44–8,66 42,17% 11,79% 0,002
Gr + flora 0,52 0,34–0,79 18,88% 30,89% <0,001
The presence P. аeroginosa 107,63 14,82–781,43 30,52% 0,41% <0,001
Step-by-step therapy 2,9 1,98–4,24 49,4% 25,2% <0,001
The presence of neutropenia 4,42 3,01–6,5 75,5% 41,06% <0,001
Neutropenia 3 st. 71,07 4,32–1168,42 12,45% 3,30% <0,001
Stage disease 3 and 4  
for the Ann-Arbor classification
1,97 1,33–2,9 37,75% 23,58% 0,001
RR> 24 per 1 minute 190,58 68,05–533,74 75,90% 1,63% <0,001
BP systolic ≤118 mmHg 6,02 3,34–10,87 28,11% 6,10% <0,001
Pulse >80 per min 7,74 5,09–11,77 61,45% 17,07% <0,001
Number of pathogens >1 8,89 5,11–15,47 39,76% 6,91% <0,001
Number of courses of HT >5 6,92 4,29–11,15 44,98% 10,57% <0,001
Leucocytes >5,9×109/liter 4,94 2,32–10,5 60,32% 23,53% <0,001
Neutrophils ≤1,7×109/l 5,47 3,66–8,15 58,23% 20,33% <0,001
Lymphocytes ≤31,8% 4 2,16–7,4 62,00% 28,99% <0,001
B CD19 ≤0,477 G/L 107,8 23,55–493,39 76,56% 2,94% <0,001
B CD19 <14,5% 5,8 2,38–14,13 44,44% 12,12% <0,001
T CD19 <42,6% 8,24 4,15–16,38 76,09% 27,85% <0,001
СD4 ≤24,73% 10,71 3,1–37,02 26,09% 3,19% <0,001
СD4 ≤0,96 G/L 4,7 2,35–9,37 71,43% 34,74% <0,001
CD8 >26,8% 2,71 1,43–5,12 43,48% 22,11% 0,002
СD4/СD8 ≤1,21 6,54 3,15–13,59 48,91% 12,77% <0,001
DR+ ≤4,3% 3,08 1,34–7,11 84,13% 63,24% 0,007
FА <31, units 5,09 2,36–10,96 59,02% 22,06% <0,001
FN <4,1, units 3,5 1,57–7,78 42,86% 17,65% 0,002
Creatinine >106,7 μmol/l 1,49 1,04–2,13 61,45% 51,63% 0,028
Urea >9,7 mmol/l 3,56 2,07–6,12 24,19% 8,23% <0,001
Hemoglobin ≤80 g/l 2,5 1,66–3,78 36,55% 18,70% <0,001
Erythrocytes ≤2,65×1012/l 4,4 2,86–6,76 43,78% 15,04% <0,001
ESR >34 mm/h 2,72 1,82–4,06 40,96% 20,33% <0,001
Platelets ≤158×109/l 1,67 1,17–2,39 54,41% 40,65% 0,004
Note: * – discrepancies according to Pearson’s χ2 criterion.
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age. (MedCalc Software bvba, Ostend, Belgium; https://www.
medcalc.org; 2017). 
The verification of the hypothesis of normal distribution 
among the quantitative characteristics studied was carried out 
according to the Shapiro-Wilka criterion and the Kolmogorov-
Smirnov criterion corrected by Lilliefors; checking the equality 
of dispersions – using Levin’s criterion. For the intergroup com-
parison of quantitative characteristics, a nonparametric disper-
sion analysis of Kraskele-Wallis was performed, pairwise com-
parison in groups was performed with corrections for multiple 
comparisons of the significance level of p. 
The probability assessment of the mean differences for quan-
titative attributes was performed according to Mann-Whitney’s 
(U) criterion; probability of differences – using the Pearson Xi-
square (χ2) criterion, with the Yates correction for continuity 
for low frequencies and the value of the indicator close to 0 or 
100. To construct the predictive model, a pairwise and multiple 
regression analysis was used to calculate the Spirman rank cor-
relation coefficients (ρ). The estimation of the significance of 
the influence of factors on the result was carried out according 
to the odds ratios (HS) from 95% confidence intervals [13]. For 
accuracy prediction, the ROC analysis was performed for logis-
tic equations, which included the construction and analysis of 
operational characteristics curves, the determination of the area 
under the ROC curve (AUC); Sensitivity (Se) and Specificity 
(Sr). [14].
resUlts And discUssion
Characteristics of patients in the study group on cancer dis-
eases were as follows: patients with chronic lymphocytic leu-
kemia – 82 (16,16%), myeloid leukemia – 29 (5,86%), Valden-
strem’s disease (VD) – 34 (6,87%), lymphoma – 26 (5,25%), 
erythema – 31 (6,26%), myeloma disease(MD) – 86 (17,37%), 
acute leukemia (AL) – 64 (12,93%) (acute lymphatic leukemia 
– 35 (7,07%), acute myeloid leukemia – 17 (3,43%), subleukemic 
myelosis – 10 (2,02%), acute monoblast leukemia – 2 (0,40%)); 
myelodysplastic syndrome – 23 (4,65%), aplastic anemia (AA) 
– 83 (16,77%), melanoma skin – 7 (1,14%), idiopathic thrombo-
cytopenic purpura – 13 (2,3%) and others – 17 (3,43%) (throm-
basthenia, lymphoproliferative diseases, hemorrhagic vasculitis, 
lymphosarcoma, plasmacytoma extemedular).
To perform the research tasks, two samples were formed: sub-
group A included 249 (50,30%) patients with pneumonia devel-
oped in the hospital with the background of a programmed HT, 
respectively, of the form and stage of oncohematological disease; 
subgroup B – 246 (49,70%) of patients without pneumonia. 
The age of the patients was in the subgroup A – 58 (46,0; 
71,0) years; in subgroup B – 65 (57,0; 72,0) years (p
А-В>0,05); the 
ratio of women to men in study subgroups is 2:3. Consequently, 
according to the age and sex categories between the groups of 
patients, no discrepancies were found, which made it possible to 
correctly compare them.
The analysis of the correlation analysis results of 132 indi-
cators of anamnesis, physical data, results of laboratory analyzes 
and immunologic indexes of patients on the background of onco-
hematological pathology revealed a connection between the pres-
ence of pneumonia and 42 quantitative and qualitative factors. 
Correlation between the presence of patients in the study groups 
of pneumonia and general clinical and laboratory parameters are 
presented in Table 1.
As a result of correlation relations, the presence of pneumo-
nia in patients of the study group was associated with complaints 
of shortness of breath, indicators of RR, ESR, pulse, temperature 
reaction, the presence of pleurisy, cough, contraction of percus-
sion sound, weakened breathing and sputum. These figures are 
signs of pneumonia or its complications, in this regard, they can 
not be the speakers of the development of pneumonia. It is impor-
tant to note that the correlation coefficients of such indicators 
as body temperature (ρ=0,3), the presence of sputum (ρ=-0,17), 
weakened breathing (ρ=0,3), ESR (ρ=-0,17) are weak and clini-
cally insignificant. This fact proves their insignificant contribu-
tion to the possibility of identifying (diagnosis) of pneumonia in 
patients, which was also stated in previous studies [15].
The results of the correlation analysis showed that the pres-
ence of pneumonia was also due to the signs of the main onco-
hematological disease of the patients in the study group: the 
number of courses of HT, preceding the occurrence of pneumonia 
(ρ=-0,37), lesion of the spleen (ρ=-0,16), damage to the lymph 
nodes (ρ=-0,12), liver damage (ρ=-0,11), stage according to the 
An-Arborsky classification (ρ=-0,12), platelets (ρ=0,11), hemo-
globin (ρ=0,17), erythrocytes (ρ=0,27).
The presence of pneumonia according to the correlation anal-
ysis was significantly influenced by the parameters of the immune 
system of patients in the study groups and other indicators that 
take an active part in anti-infective protection: neutropenia 3 st. 
(ρ=-0,26), CD4/СD8 (ρ=0,35), number of neutrophils (ρ=0,41), 
B CD19 (ρ=0,61), СD4 (ρ=0,15), lymphocytes (ρ=0,19), DR + 
(ρ=0,19), phagocytes’ activity (FA) (ρ=-0,38) and phagocyte 
number (FN) (ρ=-0,26).
For a more detailed analysis, indicators with statistically sig-
nificant, average and high correlation coefficients were selected. 
Correlation analysis showed (Table 1) that the presence of pneu-
monia is associated with feedback, first of all with indicators such 
as complaints of shortness of breath (ρ=-0,78; p<0,001), RR (ρ=-
0,62; p<0,001), the degree of neutropenia (ρ=-0,47; p<0,001), 
cough (ρ=-0,44; p<0,001) and the presence of the pathogen 
P. aeruginoza (ρ=-0,42; p<0,001) ) The most influential direct 
ligaments are the presence of pneumonia associated with the in-
dex of immunoregulatory index CD4/CD8 (ρ=0,35; p<0,001); 
the number of neutrophils (ρ=0,41; p<0,001) and B CD19, G/L 
(ρ=0,615; p<0,001). 
After determining the threshold prognostic level (Table 2) 
for quantitative factors, conducted with the help of ROC analy-
sis to determine the optimum cutoff point for assessing the ef-
fect of the studied signs on the occurrence of pneumonia, ratio of 
the chances (RC) was calculated with a 95% confidence interval. 
The analysis of the RC included all the indicators for which there 
were probable differences between the groups. 
The resulting symptom was classified in binary format, 
namely: 1 – there is pneumonia; 0 – pneumonia is absent. For 
RC, equal to 1, it means that an unfavorable result may occur in 
both groups that were compared with the same probability. The 
more RC, the more likely the occurrence of the event – the emer-
gence of pneumonia. The critical levels determined for the immu-
nogenicity indexes were: neutrophils ≤1,7×109/l, CD4 ≤24,73%, 
B CD19 ≤ 0,467 G/L, DR + ≤4,3%, CD4/CD8 ≤1,21, FA <31 
od. and FF <4,1 units (Table 2). It is important to note that the 
level of neutrophils was defined as critical in the study – neu-
trophil levels ≤ 1,7×109/l. The generally accepted critical level of 
neutrophils in the blood is below 0,5×10%, which is associated 
with the fatal outcome of IC in patients with oncohematological 
pathology [16]. 
The higher threshold obtained in our study may be explained 
by the fact that we determined it for patients with pneumonia, 
with no adverse effect. The study also did not have patients with 
sepsis. The level of neutrophils below 1,7×109/l is critical for the 
onset of pneumonia, which will allow the timely modification of 
the treatment of patients with immune disorders on the back-
ground of oncohematological diseases.
The ratio of the chances of exposure to general clinical and 
laboratory parameters for the onset of pneumonia is given in 
Table 2.
As shown the results of the assessment of RC, the presence 
of pneumonia due to the influence of a number of factors listed 
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in Table 2. The most significant influence, in addition to the 
complications of pneumonia, was among the nominal indicators: 
complaints of dyspnoea, presence of P. aeroginosa and neutrope-
nia of 3 st. Patients with these indicators have chances of devel-
oping pneumonia, respectively, in 135,5; 10,71; 107,8; and 71,07 
times more than without the presence of these factors. Among the 
quantitative indicators, the greatest influence on the occurrence 
of pneumonia is due to the parameters of the immune system: 
CD4/CD8 ≤1,21 (RC 6,54 [95% CI 3,15–13,59]); CD4 ≤24,73 
(RC 10,71 [95% CI 3,1–37,02])% CD4 ≤0,96 (RC 4,7 [95% CI 
2,35–9,37]) G/l; CD8 >26,8 (RC 2,71 [95% CI 1,43–5,12])%; B 
CD19 ≤0,47 (RC 107,8 [95% CI 23,55–493,39]) G/L; B CD19 
<14,5 (RC 5,8 [95% CI 2,38–14,13]%); T CD19 <42,6 (RC 8,24 
[95% CI 4,15–16,38])%; DR + ≤4,3 (RC 3,08 [95% CI 1,34–
7,11])%, FA <31 (RC 5,09 [95% CI 2,36–10,96]% and FN <4,1 
(RC 3,5 [95% CI 1,57–7,78])%, units (Table 2).
In this case, patients with the indicated levels of indicators 
have chances of developing pneumonia, respectively, in 107,8; 
3,08; 6,54; 5,09 and 3,5 times more than the higher than the given 
level. Thus, the state of the immune system in patients at the 
background of oncohematological pathology causes the develop-
ment of pneumonia.
For the prognosis of pneumonia in patients of the study group, 
a simple and multiple logistic regression analysis was conducted, 
in which general clinical and laboratory parameters were predic-
tors, and the dependent variable was the presence or absence of 
pneumonia. The analysis involved factors with definite statistical 
and / or clinical significance. Consequently, in a multiple logistic 
regression analysis, it was found that the following risk factors 
(in the order of decreasing the degree of influence), such as: the 
number of neutrophils, leukocytes and immunogenicity indexes – 
B CD19 + and FA, were probably (p <0,005) associated with the 
development of pneumonia.
Neutropenia and its degree in patients on the background of 
oncohematological pathology are considered by most authors as a 
risk factor for the development of infectious complications (IC), 
including pneumonia [17]. Neutrophils are a major component 
of the body’s natural defense against bacterial infections, which 
determine the extent of the immune response to the infectious 
process [16]. Neutropenia contributes to the fact that bacterial 
agents are able to multiply without restrictions and form local 
focal points in the lungs. The study also obtained data confirm-
ing that the number of neutrophils and the degree of neutropenia 
causes the emergence of pneumonia in patients with background 
oncohematological pathology.
Patients with oncohematological pathology belong to a group 
of patients with immune disorders. In the study, on a sufficient 
number of observations, it has been proved that cellular immu-
nity can be considered as predictors of pneumonia. The develop-
ment of pneumonia depends on many cellular parameters: CD4 
+%, B CD19 + G/L, DR +%, CD4/CD8, FA, units. and FN, unit. 
In the logistics equation two indicators were included – B CD19 
+, g/l and FA, units. It is known that the main effector cell-killer 
cells are T lymphocytes that provide recognition and destruction 
of cells that carry external antigens, including infectious agents 
[8]. In oncohematological diseases, the number of these cells is 
usually reduced, according to the stage or nosological form of 
the disease. The function of B lymphocytes with the B CD19 + 
phenotype is the formation of complexes with antigenic receptors 
of B-lymphocytes and a decrease in the sensitivity threshold of 
these receptors, thereby stimulating the functional activity of T 
killers [8]. 
Also, this phenotype of B-lymphocytes at their decrease char-
acterizes the redistribution of lymphocytes to the hearth of in-
flammation. Therefore, it is clear that the quantitative decrease 
in the index of B CD19 + is defined as a predictor of the occur-
rence of severe IC as a pneumonia in patients on the background 
oncohematological diseases. The obtained data coincide with the 
Table 3
Parameters of the prognostic model for the development of pneumonia in patients of the study group  
according to logistic regression analysis
prognostic variables
regression 
coefficient b
standard error of 
coefficient b
χ2 Walds
p-value χ2
Walds
Free member of the equation -2,930
Leucocytes, ×109 / l (x
1
) 0,495 0,157 9,948 0,002
Neutrophils, ×109 / l (x
2
) -1,892 0,645 8,607 0,003
B CD19, g/l (х
3
) 0,198 0,070 8,081 0,005
FA, units (x
4
) 0,080 0,031 6,742 0,009
Logistic equation
y=exp(-2,930+0,495*x
1
-1,892*x
2
+0,198*x
3
+0,080*x
4
)/
[1+exp(-2,930+0,495*x
1
-1,892*x2+0,198*x
3
+0,080*x
4
)]
Hi-square χ2= 58,60 (p<0,001)
Percentage of concordance 75,61%
Hosmer-Lemesh Test 6,188 (р=0,626)
Operating characteristics of forecasting according to ROC analysis
Sensitivity,% 72,13
Specificity,% 83,87
AUC 0,853
95% ІC AUC 0,778–0,911
р p<0,001
Qualitative evaluation of the model very kind
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data of other researchers, who determined the role of the index B 
CD19 + at its increase – as a sign of a favorable prognosis; with 
decrease – as a sign of unfavorable prognosis in patients with 
MM [18]. 
The process of phagocytosis is provided by polymorphonu-
clear granulocytes and macrophages. In conditions of reduced 
number of these cells that is observed in patients with immune 
disorders on the background of oncohematological pathology, 
the functional capacity of the existing cellular immunity, which 
is characterized by the FA index, plays a very important role. 
Phagocytic activity of leukocytes is expressed by the number of 
active leukocytes (phagocytes) in the total number of calculated 
neutrophilic leukocytes. 
It is this indicator that showed the significant effect on the 
possibility of developing pneumonia in patients on the back-
ground of oncohematological pathology. It is determined that the 
possibility of pneumonia in patients of study group, in which the 
index of FA is lower than 31 and above in 5 times than in patients 
with near-normal FA.
Consequently, from the standpoint of the possibility of de-
termining the predictors of prediction of pneumonia in patients 
with background oncohematological pathology, it is mandatory 
to take into account the secondary immunodeficiency that devel-
ops in patients as a pathogenetic basis of the underlying disease 
and potentiates modern high-dose schemes of chemotherapy. In 
developing the prognostic model based on the logistic equation, 
which suggests that the development of pneumonia is associated 
with predictors according to the formula:
y=exp(b
0+b1*x1+...+bn*xn)/[1+exp(b0+b1*x1+...+bn*xn)]
(1),
where – y – the result; b0 – free part of the regression equation; 
b1 – bn – regression coefficients; x1 – xn are predictive variables.
Regardless of the regression coefficients or the values of x, the 
predicted values (y) in this model will always be in the range from 
0 to 1 (1 is pneumonia, 0 – without pneumonia). As a result of 
the step-by-step exclusion of independent variables, parameters 
of the logistic regression equation were obtained, which included 
only the potentially significant predictors presented in Table 3.
The equation of the predictive model of the prediction of 
pneumonia in patients of the study group has the form:
PoP=exp(-2,930+0,495*x
1-1,892*x2+0,198*x3+0,080*x4)/ 
[1+exp(-2,930+0,495*x1-1,892*x2+0,198*x3+0,080*x4)]
(2),
where – POP – prognosis of pneumonia – a result that varies 
from 1 (there is pneumonia) to 0 (without pneumonia); b0 = 
-2,930 – free member of the regression equation; x1 – the number 
of leukocytes, 109 /l, х2 – the number of neutrophils, 109 /l; x3 – 
indicator B CD19+, G/l; x4 – indicator of FA, unit.
The estimation of the logistic regression equation on the 
Hi-square (χ2) value showed its adequacy: χ2=58,60; p & lt; 
0,001. As an indicator of the consistency of the real distribution 
of observations in the presence of pneumonia and distribution, 
obtained on the basis of the logistic regression equation, the 
percentage of concordance was used - the proportion is correctly 
reclassified using the equation of observation: the closer this 
figure to 100%, the higher the quality of the model. 
Taking into account the importance of the percentage of 
concordation, it can be argued that in 75,61% of cases the logistic 
regression model consisting of selected variables correctly 
predicts the development of pneumonia in patients in the study 
group. The general assessment of the agreement of the real data 
and the model was carried out using the Hosmer-Lemeshov 
consensus test (6,188; p=0,626), which, provided p>0,05, 
indicates the probability of a zero hypothesis for the coincidence 
of real and estimated data.
In order to assess the correctness of the prediction, 
the developed model was based on the AUC value, which 
indicates the dependence of the number of correctly classified 
pneumonia cases to the number of incorrectly classified cases. 
If the AUC is within the range of 0,9–1, then the quality of 
the model is considered to be excellent; within the range of 
0,8–0,9 – very good; in the range of 0,7–0,8 – good; within 
the limits of 0,6–0,7 – average; within the limits of 0,5–0,6 – 
unsatisfactory [14].
Operational characteristics of prediction of the occurrence of 
pneumonia in patients on the background of oncohematological 
pathology of the study group based on the logistic regression 
equation according to the ROC analysis are shown in Table 3 and 
on Fig. 1.
The proposed prognostic model has high operational 
characteristics: sensitivity is 72,13%, specificity – 83,87%; AUC 
is 0,853. These indicators indicate a very good estimate of the 
predicted pattern of prediction of pneumonia in patients on the 
background of oncohematological pathology.
Fig. 1. Operational characteristics of prediction of the 
occurrence of pneumonia in patients with background of 
oncohematological pathology of the study group on the basis  
of logistic regression equation according to ROC analysis
Fig. 2. Dependence of probability of occurrence of pneumonia 
for patients of the group of research from the result calculated 
according to the logistic equation
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The dependence of the probability of the occurrence of 
pneumonia for patients in the study group from the calculated 
logistical result of the equation is shown in Fig. 2/
The results of the calculation of the logistic equation of 
the theoretical values of the probability of development of 
pneumonia for patients in the study group and their visualization, 
have allowed to assert that if the calculated value of POP will be 
less than 0,23, then it is possible to assume that the event will 
not occur – the patient does not get pneumonia, because he has 
the place is low probability of an adverse result (P<20,18%). In 
other cases:
• with POP: 0,23–0,50 – moderate probability of 
development of pneumonia (20,18% ≤ P<50,08%);
• with POP 0,51–0,92 – high probability of development of 
pneumonia (50,08% ≤ P<90,45%);
• with POP higher than 0,92 – very high probability of 
development of pneumonia (P>90,45%).
Recently, the possibilities for diagnostics of IC in patients 
with background oncohematological pathology have considerably 
expanded, including due to the introduction of new diagnostic 
methods, among which prognostication has wide opportunities. 
A well-known method for predicting the risk group in children 
with acute lymphoblastic leukemia and Non-B-cell non-
Hodgkin’s lymphomas received by CT according to the protocol 
BFM-ALL-90 [19]. 
In a scientific study, as in the study, for the prediction of the 
occurrence of IC immunoglobulins were used using prognostic 
formulas to obtain an answer to which class a patient belongs 
– «without complications» or «threat of complications». The 
obtained equation of logistic regression of the prediction of the 
occurrence of pneumonia also uses modern methods for assessing 
the immune response of patients with oncohematological 
pathology. Defined in a sufficient number (495 observations) of 
the logistic regression equation when used in clinical practice, it 
will allow, on the basis of a small number of parameters available 
today in clinics of the hematological profile, to timely predict 
the development of severe IC – pneumonia and to modify the 
treatment in advance to reduce the days of hospital stay and 
improvement quality of life for patients. The expected long-term 
outcome may be a reduction in mortality.
conclUsions
1. Based on the statistical analysis of the complex of clin-
ical-laboratory, anamnestic and immunological parameters of 
495 patients, predictors of pneumonia in patients with immune 
disorders were identified on the background of oncohemato-
logical pathology. The results of the study prove that the prob-
ability of pneumonia in patients with oncohematological pa-
thology is to a large extent conditioned by the state of immune 
reactivity of patients: Among the quantitative indicators, the 
greatest influence on the occurrence of pneumonia is due to 
the parameters of the immune system: CD4/СD8 ≤1,21 (RC 
6,54 [95% CI 3,15–13,59]); CD4 ≤24,73 (RC 10,71 [95% CI 
3,1–37,02])% CD4 ≤0,96 (RC 4,7 [95% CI 2,35–9,37]) G/L; 
CD8 > 26,8 (RC 2,71 [95% CI 1,43–5,12])%; B CD19+ ≤0,47 
(RC 107,8 [95% CI 23,55–493,39]) G/L; B CD19+ <14,5 (RC 
5,8 [95% CI 2,38–14,13]%); T CD19 <42,6 (RC 8,24 [95% CI 
4,15–16,38])%; DR + ≤4,3 (RC 3,08 [95% CI 1,34–7,11])%, 
FA <31 (RC 5,09 [95% CI 2,36–10,96]% and FN <4,1 (RC 3,5 
[95% CI 1,57–7,78])%, units.
2. According to the results of the study, the logistic regression 
equation for the prediction of the occurrence of pneumonia in pa-
tients on the background of oncological pathology was obtained:
PoP = exp (-2,930 + 0,495*x
1-1,892*x2 + 0,198*x3 + 0,080*x4) / 
[1 + exp (-2,930 + 0,495*x1-1,892*x2 + 0,198*x3 + 0,080*x4)]]
where – POP – prognosis of pneumonia; b0 = -2,930 – free 
member of the regression equation; x1 – the number of leuko-
cytes, 109 /l, х2 – the number of neutrophils, 10
9 /l; x3 – B CD19, 
T/L; x4 – index of phagocytic activity, unit. At a value of POP 
less than 0,23 – very low probability of development of pneu-
monia; at 0,23–0,50 – moderate probability of development of 
pneumonia; at 0,51–0,92 – high probability of development of 
pneumonia; more than 0,92 – very high probability of develop-
ment of pneumonia.
3. Based on the statistical analysis of the complex of clinical-
laboratory, anamnestic and immunological parameters of 495 
patients, the logistic regression equation for prediction of fatal 
consequences in patients with pneumonia in the background of 
oncological diseases of the blood has excellent operational char-
acteristics: the sensitivity is 72,13%, the specificity is 83,87%, 
AUC – 0,853.
4. The obtained logistic regression equation for the prediction 
of the occurrence of pneumonia when used in clinical practice in 
patients with immune disorders on the background of cancer pa-
thology will allow predicting the onset of pneumonia based on a 
small number of parameters available today in oncohematologi-
cal centers and specialized departments. The probable prognosis 
regarding the occurrence of pneumonia in patients with immune 
disorders on the background of oncohematological pathology will 
allow them to optimize their treatment in advance and reduce the 
mortality and the number of days of hospitalization in this regard.
Прогноз развития пневмоний у больных 
с нарушениями иммунитета на фоне 
онкогематологической патологии
И.С. Борисова
В исследовании на основе статистического анализа комплекса 
клинико-лабораторных, анамнестических и иммунологических 
показателей 495 больных с нарушениями иммунитета на фоне он-
когематологической патологии определены предикторы развития 
пневмоний и создана регрессионная логистическая модель прогно-
за развития пневмоний, куда вошли показатели, которые характе-
ризуют течение онкогематологического заболевания и состояние 
иммунной системы.
Ключевые слова: прогноз развития пневмонии, онкогематологиче-
ская патология, нарушение иммунитета.
Прогноз розвитку пневмоній у хворих  
з порушеннями імунітету на тлі 
онкогематологічної патології
І.С. Борисова
У дослідженні на підставі статистичного аналізу комплексу клініко-
лабораторних, анамнестичних та імунологічних показників 495 хво-
рих з порушеннями імунітету на тлі онкогематологічної патології 
визначені предиктори розвитку пневмоній і створена регресійна 
логістична модель прогнозу розвитку пневмоній, куди увійшли по-
казники, які характеризують перебіг онкогематологічного захво-
рювання і стан імунної системи.
Ключові слова: прогноз розвитку пневмонії, онкогематологічна 
патологія, порушення імунітету.
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